African Programme for Onchocerciasis Control 1995– 2015 : Model-Estimated Health Impact and Cost

Onchocerciasis causes a considerable disease burden in Africa, mainly through skin and eye disease. Since 1995, the African Programme for Onchocerciasis Control (APOC) has coordinated annual mass treatment with ivermectin in 16 countries. In this study, we estimate the health impact of APOC and the...

Full description

Bibliographic Details
Main Authors: Coffeng, Luc E., Stolk, Wilma A., Zoure, Honorat G. M., Veerman, J. Lennert, Agblewonu, Koffi B.
Format: Journal Article
Language:en_US
Published: Public Library of Science 2015
Subjects:
Online Access:http://hdl.handle.net/10986/23206
id okr-10986-23206
recordtype oai_dc
spelling okr-10986-232062021-04-23T14:04:13Z African Programme for Onchocerciasis Control 1995– 2015 : Model-Estimated Health Impact and Cost Coffeng, Luc E. Stolk, Wilma A. Zoure, Honorat G. M. Veerman, J. Lennert Agblewonu, Koffi B. Onchocerciasis river blindness health impact health cost Onchocerciasis causes a considerable disease burden in Africa, mainly through skin and eye disease. Since 1995, the African Programme for Onchocerciasis Control (APOC) has coordinated annual mass treatment with ivermectin in 16 countries. In this study, we estimate the health impact of APOC and the associated costs from a program perspective up to 2010 and provide expected trends up to 2015. 2015-12-03T21:51:34Z 2015-12-03T21:51:34Z 2013-01-31 Journal Article PLoS Neglected Tropical Diseases http://hdl.handle.net/10986/23206 en_US CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo World Bank Public Library of Science Publications & Research :: Journal Article Publications & Research
repository_type Digital Repository
institution_category Foreign Institution
institution Digital Repositories
building World Bank Open Knowledge Repository
collection World Bank
language en_US
topic Onchocerciasis
river blindness
health impact
health cost
spellingShingle Onchocerciasis
river blindness
health impact
health cost
Coffeng, Luc E.
Stolk, Wilma A.
Zoure, Honorat G. M.
Veerman, J. Lennert
Agblewonu, Koffi B.
African Programme for Onchocerciasis Control 1995– 2015 : Model-Estimated Health Impact and Cost
description Onchocerciasis causes a considerable disease burden in Africa, mainly through skin and eye disease. Since 1995, the African Programme for Onchocerciasis Control (APOC) has coordinated annual mass treatment with ivermectin in 16 countries. In this study, we estimate the health impact of APOC and the associated costs from a program perspective up to 2010 and provide expected trends up to 2015.
format Journal Article
author Coffeng, Luc E.
Stolk, Wilma A.
Zoure, Honorat G. M.
Veerman, J. Lennert
Agblewonu, Koffi B.
author_facet Coffeng, Luc E.
Stolk, Wilma A.
Zoure, Honorat G. M.
Veerman, J. Lennert
Agblewonu, Koffi B.
author_sort Coffeng, Luc E.
title African Programme for Onchocerciasis Control 1995– 2015 : Model-Estimated Health Impact and Cost
title_short African Programme for Onchocerciasis Control 1995– 2015 : Model-Estimated Health Impact and Cost
title_full African Programme for Onchocerciasis Control 1995– 2015 : Model-Estimated Health Impact and Cost
title_fullStr African Programme for Onchocerciasis Control 1995– 2015 : Model-Estimated Health Impact and Cost
title_full_unstemmed African Programme for Onchocerciasis Control 1995– 2015 : Model-Estimated Health Impact and Cost
title_sort african programme for onchocerciasis control 1995– 2015 : model-estimated health impact and cost
publisher Public Library of Science
publishDate 2015
url http://hdl.handle.net/10986/23206
_version_ 1764453200216195072